COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

被引:0
|
作者
Joshua Elliott
Barbara Bodinier
Matthew Whitaker
Cyrille Delpierre
Roel Vermeulen
Ioanna Tzoulaki
Paul Elliott
Marc Chadeau-Hyam
机构
[1] Imperial College London,Department of Epidemiology and Biostatistics, School of Public Health
[2] St Mary’s Hospital,MRC Centre for Environment and Health
[3] Norfolk Place,UMR LEASP
[4] Imperial College,Department of Hygiene and Epidemiology
[5] Royal Surrey County Hospital,Institute for Risk Assessment Sciences (IRAS)
[6] Université de Toulouse III,undefined
[7] UPS,undefined
[8] Inserm,undefined
[9] University of Ioannina Medical School,undefined
[10] Utrecht University,undefined
来源
关键词
COVID-19 mortality; SARS-CoV-2; Prospective cohort; UK biobank; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18–3.49] per S.D. [8.1 years], p = 2.6 × 10–17), male sex (OR = 1.47 [1.26–1.73], p = 1.3 × 10–6) and Black versus White ethnicity (OR = 1.21 [1.12–1.29], p = 3.0 × 10–7) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin–angiotensin–aldosterone system inhibitors may be explained by the aforementioned factors.
引用
收藏
页码:299 / 309
页数:10
相关论文
共 50 条
  • [31] Response to: Correspondence on 'Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank' by Jolobe
    Raisi-Estabragh, Zahra
    Harvey, Nicholas C.
    Petersen, Steffen E.
    HEART, 2023, 109 (04) : 332 - 333
  • [32] COVID-19: Risk factors for increased mortality in younger COVID-19 patients
    不详
    ERNAHRUNGS UMSCHAU, 2022, 69 (06): : M297 - M297
  • [33] Frailty and comorbidity in predicting community COVID-19 mortality in the UK Biobank: The effect of sampling
    Mak, Jonathan K. L.
    Kuja-Halkola, Ralf
    Wang, Yunzhang
    Hagg, Sara
    Jylhava, Juulia
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (05) : 1128 - 1139
  • [34] Dietary Behaviors and Incident COVID-19 in the UK Biobank
    Vu, Thanh-Huyen T.
    Rydland, Kelsey J.
    Achenbach, Chad J.
    Van Horn, Linda
    Cornelis, Marilyn C.
    NUTRIENTS, 2021, 13 (06)
  • [35] Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data
    Chadeau-Hyam, Marc
    Bodinier, Barbara
    Elliott, Joshua
    Whitaker, Matthew D.
    Tzoulaki, Ioanna
    Vermeulen, Roel
    Kelly-Irving, Michelle
    Delpierre, Cyrille
    Elliott, Paul
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2020, 49 (05) : 1454 - 1467
  • [36] Childhood adversity and COVID-19 outcomes in the UK Biobank
    Hanson, Jamie L.
    O'Connor, Kristen
    Adkins, Dorthea J.
    Kahhale, Isabella
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2024, 78 (02) : 75 - 81
  • [37] Clinical Characteristics and Risk Factors for Mortality in COVID-19 Patients: A Retrospective Cohort Study
    Khajoei, Rahimeh
    Heydarpour, Nabiollah
    Sadeghi, Reza
    Balvardi, Mohadeseh
    Jafari, Hamid
    Shokohian, Sajad
    Rahmani, Farzad
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (05) : LC9 - LC14
  • [38] Alcohol intake and mortality risk of COVID-19, pneumonia, and other infectious diseases: An analysis of 437191 UK biobank participants
    Huang, Bo-Huei
    Inan-Eroglu, Elif
    Shaban, Ramon Z.
    Hamer, Mark
    Britton, Annie
    Stamatakis, Emmanuel
    PREVENTIVE MEDICINE REPORTS, 2022, 26
  • [39] Association between ethnic background and COVID-19 morbidity, mortality and vaccination in England: a multistate cohort analysis using the UK Biobank
    Urdiales, Tomas
    Dernie, Francesco
    Catala, Marti
    Prats-Uribe, Albert
    Prats, Clara
    Prieto-Alhambra, Daniel
    BMJ OPEN, 2023, 13 (09):
  • [40] Associations of obesity, physical activity level, inflammation and cardiometabolic health with COVID-19 mortality: a prospective analysis of the UK Biobank cohort
    Hamrouni, Malik
    Roberts, Matthew J.
    Thackray, Alice
    Stensel, David J.
    Bishop, Nicolette
    BMJ OPEN, 2021, 11 (11):